Literature DB >> 18954598

More than 150 consecutive open umbilical hernia repairs in a major Veterans Administration Medical Center.

Buckminster Farrow1, Samir Awad, David H Berger, Daniel Albo, Liz Lee, Anu Subramanian, Charles F Bellows.   

Abstract

BACKGROUND: The purpose of this study was to determine the rate of surgical site infection for open elective umbilical hernia repairs and to identify the factors related to an increased risk of infection and/or recurrence.
METHODS: A retrospective analysis of 152 open elective umbilical hernia repairs between 2003 and 2007 was performed.
RESULTS: Overall, 19% of repairs became infected. Both high ASA classification (P = .01) and mesh repair (P = .01) significantly predicted wound infection, whereas age >60 years, body mass index >30, smoking, immunosuppression, diabetes, and hernia size did not. Only 2 of 17 infected mesh repairs required removal of the mesh. The recurrence rate was 1.5% for mesh and 9.2% for suture repairs.
CONCLUSIONS: Umbilical hernia repair is associated with a high rate of infection, and most superficial mesh infections can be treated with antibiotics alone. In addition, mesh repair of umbilical hernias decreased the rate of recurrence but increased the risk of infection compared with suture repairs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18954598     DOI: 10.1016/j.amjsurg.2008.07.018

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  19 in total

Review 1.  Current options in umbilical hernia repair in adult patients.

Authors:  Hakan Kulaçoğlu
Journal:  Ulus Cerrahi Derg       Date:  2015-09-01

2.  Long-term follow-up after elective adult umbilical hernia repair: low recurrence rates also after non-mesh repairs.

Authors:  J Dalenbäck; C Andersson; D Ribokas; G Rimbäck
Journal:  Hernia       Date:  2012-09-13       Impact factor: 4.739

3.  Retrospective analysis of umbilical, epigastric, and small incisional hernia repair using the Ventralex™ hernia patch.

Authors:  T Tollens; M Den Hondt; K Devroe; C Terry; S Speybroeck; C Aelvoet; J-P Vanrykel
Journal:  Hernia       Date:  2011-04-13       Impact factor: 4.739

Review 4.  A Collective Review on Mesh-Based Repair of Umbilical and Epigastric Hernias.

Authors:  Jeroen E H Ponten; Irene Thomassen; Simon W Nienhuijs
Journal:  Indian J Surg       Date:  2013-04-28       Impact factor: 0.656

5.  Lower reoperation rate for recurrence after mesh versus sutured elective repair in small umbilical and epigastric hernias. A nationwide register study.

Authors:  M W Christoffersen; F Helgstrand; J Rosenberg; H Kehlet; T Bisgaard
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

6.  Single centre observational study to evaluate the safety and efficacy of the Proceed™ Ventral Patch to repair small ventral hernias.

Authors:  J Bontinck; I Kyle-Leinhase; P Pletinckx; V Vergucht; R Beckers; F Muysoms
Journal:  Hernia       Date:  2013-07-24       Impact factor: 4.739

7.  Prosthetic repair of umbilical hernias in adults with local anesthesia in a day-case setting: a comprehensive report from a specialized hernia center.

Authors:  H Kulacoglu; D Yazicioglu; I Ozyaylali
Journal:  Hernia       Date:  2011-10-22       Impact factor: 4.739

8.  Umbilical hernia management during liver transplantation.

Authors:  B de Goede; B J H van Kempen; W G Polak; R J de Knegt; J N L Schouten; J F Lange; H W Tilanus; H J Metselaar; G Kazemier
Journal:  Hernia       Date:  2013-06-23       Impact factor: 4.739

9.  History of methicillin-resistant Staphylococcus aureus (MRSA) surgical site infection may not be a contraindication to ventral hernia repair with synthetic mesh: a preliminary report.

Authors:  C W Hicks; J A Blatnik; D M Krpata; Y W Novitsky; M J Rosen
Journal:  Hernia       Date:  2013-01-18       Impact factor: 4.739

10.  External validation of the ventral hernia risk score for prediction of surgical site infections.

Authors:  Mike K Liang; Christopher J Goodenough; Robert G Martindale; J Scott Roth; Lillian S Kao
Journal:  Surg Infect (Larchmt)       Date:  2015-02       Impact factor: 2.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.